Mann Michael Scott

President, 10% OwnerENDONOVO THERAPEUTICS, INC. (E) · full profile →Form 4 · filed Apr 19, 2017
Net Buying
Open-Market Buys
$1K
Open-Market Sells
$0
Net Open-Market Flow
$1K
Transactions
12
12 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 18, 2017Buy(P)1K$0.06$6020.2M
Apr 18, 2017Buy(P)1K$0.06$6020.2M
Apr 18, 2017Buy(P)1K$0.06$6020.2M
Apr 18, 2017Buy(P)1K$0.65$65020.2M
Apr 18, 2017Buy(P)1K$0.06$6020.2M
Apr 18, 2017Buy(P)1K$0.06$6020.2M
Apr 18, 2017Buy(P)1K$0.06$6020.2M
Apr 18, 2017Buy(P)1K$0.06$6020.2M
Apr 18, 2017Buy(P)1K$0.05$5020.2M
Apr 18, 2017Buy(P)1K$0.06$6020.2M
Apr 17, 2017Buy(P)1K$0.05$5020.2M
Apr 17, 2017Buy(P)1K$0.05$5020.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001645627-17-000037) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Keep exploring

Connected pages for ENDONOVO THERAPEUTICS, INC.

Build

Ask your agent about E insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001645627-17-000037"
Ask your agent
Use Arkolith to summarize insider buying and selling at ENDONOVO THERAPEUTICS, INC.
over the last 90 days and cite the filings.